Further investigation is needed to determine whether fenfluramine treatment can slow or alter the natural history of SCN8A‐epilepsy as a syndromic condition, including amelioration of the neurodevelopmental delay and regression that lead to psychomotor, behavioral, language, and intellectual impairment. The gene discussed is SCN8A; the disease is Cognitive impairment.